Refine by
Brineura Allergic Reactions Equipment & Supplies
1 equipment items found
Manufactured by:BioMarin based inSan Rafael, CALIFORNIA (USA)
The first approved treatment for any form of Batten disease. Brineura (cerliponase alfa) is indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency. Brineura is the first enzyme replacement therapy to be directly administered into ...